Increasing PTS using multimodal data

Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.

Feb 16, 2023
Life Sciences
Webinar
Iker HuergaSVP, Life Sciences Strategy, Tempus
Leora Horn, MDGlobal Clinical Head for Lung Cancer & Lung Cancer Strategy, AstraZeneca